Allopurinol Tablet
Product Images NDC 43063-976

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Allopurinol (NDC 43063-976). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

43063976 Label (43063976)

Label for Allopurinol USP 300 mg oral tablets from PD-Rx Pharmaceuticals, Inc. The label indicates a quantity of 30 tablets and includes NDC 43063-976-30. It features dosage warnings and instructions in English and Spanish, batch information (lot D22A48), and expiration date (12/2023). The label also shows barcodes, a QR code, and manufacturer information located in Oklahoma City, OK.*

FDA Label Image

Structure (Allopurinol 01)

Chemical structure of allopurinol, showing its molecular framework with nitrogen and oxygen atoms arranged in a purine analog configuration as seen in the product data for allopurinol tablets.*

FDA Label Image

Figure (Allopurinol 02)

Chemical structure diagram illustrating the conversion pathways between Allopurinol (1,5-dihydro-4H-pyrazolo-[3,4-d]pyrimidin-4-one), Oxipurinol (1H-pyrazolo [3,4-d]pyrimidine, 4,6 (5H,7H)-dione), Hypoxanthine, Xanthine, and Uric Acid, showing molecular transformations and relationships among these compounds.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.